A detailed history of Intech Investment Management LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Intech Investment Management LLC holds 11,986 shares of EXAS stock, worth $688,955. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,986
Previous 11,584 3.47%
Holding current value
$688,955
Previous $489,000 66.87%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$42.43 - $70.83 $17,056 - $28,473
402 Added 3.47%
11,986 $816,000
Q2 2024

Aug 12, 2024

BUY
$41.33 - $74.26 $4,794 - $8,614
116 Added 1.01%
11,584 $489,000
Q1 2024

May 10, 2024

SELL
$56.27 - $73.77 $10,466 - $13,721
-186 Reduced 1.6%
11,468 $791,000
Q4 2023

Oct 18, 2024

SELL
$59.06 - $75.72 $83,274 - $106,765
-1,410 Reduced 10.79%
11,654 $862,000
Q4 2023

Feb 09, 2024

SELL
$59.06 - $75.72 $83,274 - $106,765
-1,410 Reduced 10.79%
11,654 $862,000
Q3 2023

Oct 18, 2024

BUY
$65.94 - $99.04 $337,876 - $507,480
5,124 Added 64.53%
13,064 $891,000
Q3 2023

Nov 13, 2023

BUY
$65.94 - $99.04 $337,876 - $507,480
5,124 Added 64.53%
13,064 $891,000
Q2 2023

Oct 18, 2024

SELL
$62.68 - $95.05 $344,990 - $523,155
-5,504 Reduced 40.94%
7,940 $745,000
Q2 2023

Aug 09, 2023

SELL
$62.68 - $95.05 $344,990 - $523,155
-5,504 Reduced 40.94%
7,940 $745,000
Q1 2023

Oct 18, 2024

BUY
$47.19 - $70.77 $87,773 - $131,632
1,860 Added 16.06%
13,444 $911,000
Q1 2023

May 10, 2023

SELL
$47.19 - $70.77 $31,853 - $47,769
-675 Reduced 4.78%
13,444 $911,000
Q4 2022

Oct 18, 2024

BUY
$30.35 - $53.15 $17,269 - $30,242
569 Added 4.2%
14,119 $699,000
Q4 2022

Feb 09, 2023

BUY
$30.35 - $53.15 $17,269 - $30,242
569 Added 4.2%
14,119 $699,000
Q3 2022

Oct 18, 2024

BUY
$31.97 - $49.37 $62,853 - $97,061
1,966 Added 16.97%
13,550 $440,000
Q2 2022

Aug 10, 2022

BUY
$35.61 - $76.23 $482,515 - $1.03 Million
13,550 New
13,550 $534,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.